Supreme Court: IBC Mechanism Cannot Replace Decree Execution or Recovery Proceedings || SC Orders Closure of School Over Loan Default, Directs Police-Assisted Takeover under SARFAESI Act || MP HC: HC Lacks Jurisdiction to Appoint an Arbitrator in International Commercial Disputes || Allahabad HC Imposes Rs 15L Costs on Husband For Filing False Affidavits in Maintenance Proceedings || MP HC Directs ASI to Upload Bhojshala–Kamal Maula Survey Video on Secure Platform For Litigant || Bombay HC: Public Gathering Does Not Justify Handcuffing, Awarded ?50,000 Compensation || Madras HC: Woman’s Dignity Linked to Right to Shelter; Orders Restoration of Demolished Home || SC: Absence of Independent Witnesses is Not Fatal if Injured Eyewitness Testimony is Sterling || Supreme Court: Prosthetic Limb Costs Must Be Compensated To Restore Victims’ Dignity || Supreme Court: Probate Can be Revoked For Non-Impleadment of Parties and Suppression of Facts

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :